|
If you are an affected
investor in any of the cases below,
you may wish to contact
us.
Motorola,
Inc. (NYSE: MOR)
Investors
who purchased Motorola between July 19, 2006 and January 4, 2007
may be affected.
It
is alleged that in order to artificially inflate the price of
Motorola stock, in the summer of 2006 the Company began a series
of false and misleading statements regarding its business and
prospects. Specifically,
investors were told to expect strong growth in sales and revenues.
But in announcements the Company made in October 2006 and
January 2007 it was clear the Company would not make these
expectations and Motorola stock tumbled when its true condition
was disclosed.
Luminent
Mortgage Capital, Inc. (NYSE: LUM)
Investors
who purchased between October 10, 2006 and August 6, 2007 may be
affected.
On
August 6, 2007 the Company issued a press release announcing that
the secondary market for mortgage loans and mortgage-backed
securities had “seized-up” and that as a result the Company
was experiencing a significant increase in margin calls on its
highest quality assets. As
a result, the Company’s stock experienced a one-day decline of
75%.
Heelys,
Inc. (NASDAQ: HLYS)
Investors
who purchased Heelys’ stock since its December 8, 2006 IPO
through August 7, 2007, may be affected.
On
August 7, 2007 Heelys reported its third quarter and full year
forecasts would be below analyst projections. On August 8, 2007, Heelys shares declines approximately 48%
to close at $11.42 per share.
GPC
Biotech AG (NASDAQ: GPCB)
Investors
who purchased GPC between December 5, 2005 and July 24, 2007 may
be affected.
On
July 24, 2007, The FDA announced that its oncology panel had
unanimously recommended against the approval of Satraplatin.
The Committee said the FDA had no prior experience with
that type of endpoint, an issue which was “clearly
communicated” to GPC Biotech while the drug was in development.
As a result GPC stock fell approximately 35% on July 25,
2007.
Pall
Corporation (NYSE: PLL)
Investors
who purchased Pall securities within the past 5 years may be
affected.
On
July 19, 2007 the Company disclosed that a board committee began
an inquiry into a possible material understatement of US income
tax payments. On
August 2, 2007, the Company disclosed that its annual and
quarterly financial statements for the fiscal years 1999 through
2006 and the first three quarters of 2007 should no longer be
relied upon and may need to be restated.
CV
Technologies (Toronto Exchange – CVQ.TO)
Investors
who purchased CVT between December 11, 2006 and March 23, 2007 may
be affected.
On
April 11, 2007, CVT announced that the Company decided that its
consolidated financial statements for the year ended September 30,
2006, as well as its interim consolidated financial statements for
the first quarter of fiscal 2007 warranted restatement due to a
revenue deferral issue in the US market.
RTI
International Metals (NYSE: RTI)
On
July 25, 2007, before the opening of trading, the Company
disclosed that US Customs and Border Protection was investigating
claims filed by the Company to obtain reimbursement of duty paid
by the Company on certain imports.
If you are an affected investor,
you may wish to contact
us. |
